Search

everythinglearnresearchcommunity

for

Search:↓

Different medications can cause serious side effects in some people.

Some medications can cause hair loss, and it's important to track when the hair loss starts after taking a new medication.

Valproic acid does not change biotinidase enzyme activity in children's blood.

Some antiepileptic drugs can cause weight gain and hair loss, especially in women.

Valproic acid treatment may cause temporary hair loss due to reduced zinc and biotinidase levels, which tend to normalize after 6 months.

Intralesional triamcinolone is more effective than topical betamethasone for treating localized alopecia areata.

Pili torti is a rare condition where hair is twisted and breaks easily, often linked to genetic disorders or other health issues.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

Oral isotretinoin temporarily improved skin symptoms in a child with IFAP syndrome.

Genetic variants can affect valproic acid's effectiveness, side effects, and levels in epilepsy treatment.

Valproic acid may cause hair loss by reducing biotinidase enzyme activity in rats.

Use NSAIDs for immediate migraine relief and β-blockers for prevention; tailor treatment to the individual.

Sumatriptan injections, high-flow oxygen, and verapamil effectively treat cluster headaches.

Vitamin A affects hair loss and immune response in alopecia areata.

Some psychotropic medications can rarely cause hair loss, and stopping these drugs usually reverses the condition.

Carbamazepine may cause lung problems and lupus-like symptoms, which can improve after stopping the drug.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

People with migraines often have mental health conditions, and treatment should be personalized to address both issues safely.

Four new cases of Bachmann-Bupp syndrome suggest potential for targeted treatment.

Mesotherapy is not significantly better than minoxidil for treating male hair loss.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

The conclusion is that careful management of both psychiatric and skin conditions is crucial for HIV patients, using medication and interdisciplinary approaches.

Black cumin and its nanoformulations show promise in treating neurodegenerative diseases.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Natural products may help treat hair loss by promoting hair growth with fewer side effects.

Levetiracetam and valproate sodium both reduce seizures when added to lamotrigine, but levetiracetam has fewer side effects.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.